Target intelligence / Profile preview

Human DNA polymerases (DNA Pol)

Target
DNA Pol
Molecular classification
Enzyme, Transferase, DNA-directed DNA polymerase
01

Overview

Human DNA polymerases are a group of essential enzymes responsible for the synthesis and repair of DNA in both the nucleus and mitochondria. The nuclear polymerases, including families A, B, X, and Y, perform distinct roles such as bulk genomic replication (Pol alpha, delta, epsilon) and specialized DNA repair (Pol beta, lambda, mu) [StatPearls, 2023]. The mitochondrial DNA polymerase, Pol gamma, is the sole enzyme responsible for the replication and maintenance of the mitochondrial genome [UniProt P54098]. These enzymes are critical therapeutic targets; for example, many nucleoside analog chemotherapies like Cytarabine and Gemcitabine target nuclear polymerases to inhibit cancer cell proliferation [PubMed, 2021]. However, they are also significant sites of off-target drug toxicity. Specifically, the inhibition of Pol gamma by certain antiviral nucleoside reverse transcriptase inhibitors (NRTIs) can lead to mitochondrial DNA depletion, resulting in severe clinical conditions such as lactic acidosis, myopathy, and lipodystrophy [NIH, 2022]. Furthermore, mutations in polymerase genes like POLE and POLD1 serve as important biomarkers for hypermutation status and immunotherapy sensitivity in various cancers [PubMed, 2019].

Other names
DNA-directed DNA polymeraseNuclear DNA polymerasesMitochondrial DNA polymeraseDNA polymerase gamma (POLG)DNA polymerase alpha (POLA)DNA polymerase beta (POLB)DNA polymerase delta (POLD)DNA polymerase epsilon (POLE)
02

Mechanism of action

Inhibition of DNA synthesis through competitive binding with deoxyribonucleotide triphosphates (dNTPs) or by acting as chain terminators after incorporation into the nascent DNA strand [StatPearls, 2023].

03

Biological functions

DNA replicationDNA repairMitochondrial genome maintenanceTelomere maintenance
04

Disease associations

CancerMitochondrial DNA depletion syndromeViral infectionAlpers-Huttenlocher syndrome
05

Safety considerations

Mitochondrial toxicityLactic acidosisMyelosuppressionPeripheral neuropathyHepatic steatosis
06

Interacting drugs

Cytarabine

8 more in the full profile.

07

Biomarkers

POLG mutation statusPOLE mutation statusMitochondrial DNA copy numberMicrosatellite instability (MSI)

Beyond the preview

Go deeper on Human DNA polymerases (DNA Pol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human DNA polymerases (DNA Pol).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call